Wednesday, Nov 18, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | India | Russia To Produce Sputnik V Covid Vaccine In India

Russia to produce Sputnik V Covid vaccine in India

According to the RDIF -- Russia's sovereign wealth fund, the vaccine's interim clinical trial results show 95 per cent efficacy on the 42nd day after the first dose.

By IANS
Published Date - 27 November 2020, 01:02 PM
Russia to produce Sputnik V Covid vaccine in India
Representational Image
whatsapp facebook twitter telegram

Moscow: The Russian Direct Investment Fund (RDIF) and Hetero, one of India’s generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year of Sputnik V Covid-19 vaccine in India.

The parties intend to start the production of Sputnik V at the beginning of 2021.


“We are pleased to collaborate with RDIF as a manufacturing partner for the most anticipated Sputnik V vaccine for the treatment of Covid-19,” Murali Krishna Reddy, Director, International Marketing, Hetero Labs Limited said in a statement.

“This collaboration is another step towards our commitment in the battle against Covid-19 and realizing the objective of ‘Make-in-India’ campaign as envisioned by our Prime Minister of India,” Reddy added.

According to the RDIF — Russia’s sovereign wealth fund, the vaccine’s interim clinical trial results show 95 per cent efficacy on the 42nd day after the first dose.

Currently, Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries, as well as Phase II-III in India.

Requests for more than 1.2 billion doses of Sputnik V vaccine came from more than 50 countries.

The vaccine supplies for the global market will be produced by RDIF’s international partners in India, Brazil, China, South Korea and other countries.

“We are delighted to announce the agreement between RDIF and Hetero that will pave the way to the production of the safe and highly effective Sputnik V vaccine on Indian soil,” Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said in a statement.

“Thanks to our cooperation with Hetero, we will be able to significantly increase production capacity and provide people of India with an efficient solution in this challenging period of the pandemic,” Dmitriev added.

The Russian vaccine uses two different vectors based on the human adenovirus, rather than using one and the same vector for two doses.

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • clinical trials
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India

Related News

  • Groundwater depletion raises summer water concerns in Medchal district

    Groundwater depletion raises summer water concerns in Medchal district

  • Farmers in Karnataka protest, seek water for chilli crops

    Farmers in Karnataka protest, seek water for chilli crops

  • BRS MLC Dasoju Sravan seeks ACB probe into alleged commission culture

    BRS MLC Dasoju Sravan seeks ACB probe into alleged commission culture

  • BRS chief KCR invited to Ayyappa Swamy Maha Padi Puja

    BRS chief KCR invited to Ayyappa Swamy Maha Padi Puja

Latest News

  • Apple restores most services after internal software update triggers outage; rules out cyberattack

    5 minutes ago
  • Microsoft unveils AI models, Copilot platform and Azure upgrades at Ignite

    22 minutes ago
  • KTR launches ‘Game Changers’ book chronicling journeys of 20 everyday heroes

    30 minutes ago
  • Chip curbs, mineral supplies test Trump’s China diplomacy ahead of Xi talks

    39 minutes ago
  • Dhanush thanks Dhoni after CSK exit as player, says game will never be the same

    55 minutes ago
  • Fire destroys furniture shop in Shankarpally; no casualties reported

    1 hour ago
  • Sensex falls 370 points, Nifty drops below 25,250 amid profit-taking

    1 hour ago
  • Israel elects Netanyahu opponent Matan Kahana as parliament speaker amid coalition talks

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App